Flubendazole
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB08974 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | urinary bladder carcinoma | KG + DL |
| 2 | urinary bladder neoplasm | KG + DL |
| 3 | infiltrating bladder urothelial carcinoma | KG + DL |
| 4 | non-invasive bladder urothelial carcinoma | KG + DL |
| 5 | bladder urachal urothelial carcinoma | KG + DL |
| 6 | bladder squamous papilloma | KG + DL |
| 7 | bladder signet ring cell adenocarcinoma | KG + DL |
| 8 | bladder colonic type adenocarcinoma | KG + DL |
| 9 | bladder colloid adenocarcinoma | KG + DL |
| 10 | bladder mixed adenocarcinoma | KG + DL |
| 11 | bladder clear cell adenocarcinoma | KG + DL |
| 12 | bladder urothelial papilloma | KG + DL |
| 13 | bladder leiomyoma | KG + DL |
| 14 | colonic neoplasm | KG + DL |
| 15 | bladder dome cancer | KG + DL |
| 16 | urachus cancer | KG + DL |
| 17 | bladder neck cancer | KG + DL |
| 18 | cecum villous adenoma | KG + DL |
| 19 | colonic lymphangioma | KG + DL |
| 20 | cecum neuroendocrine tumor G1 | KG + DL |
| 21 | bladder lateral wall cancer | KG + DL |
| 22 | urinary bladder anterior wall cancer | KG + DL |
| 23 | bladder sarcoma | KG + DL |
| 24 | lipoma of colon | KG + DL |
| 25 | rectosigmoid junction neoplasm | KG + DL |
| 26 | cecal disease | KG + DL |
| 27 | benign neoplasm of cecum | KG + DL |
| 28 | cavernous hemangioma of colon | KG + DL |
| 29 | colon leiomyoma | KG + DL |
| 30 | bladder urachal adenocarcinoma | KG + DL |
| 31 | non-papillary transitional cell carcinoma of the bladder | KG + DL |
| 32 | drug-induced osteoporosis | KG + DL |
| 33 | urinary bladder cancer | KG + DL |
| 34 | palmoplantar keratoderma, nonepidermolytic, focal 1 | KG + DL |
| 35 | odontogenic cyst | KG + DL |
| 36 | cervical neuroblastoma | KG + DL |
| 37 | pre-malignant neoplasm | KG + DL |
| 38 | bladder carcinoma in situ | KG + DL |
| 39 | nasopharyngeal teratoma | KG + DL |
| 40 | cystic neoplasm | KG + DL |
| 41 | benign neoplasm of buccal mucosa | KG + DL |
| 42 | tumor of testis and paratestis | KG + DL |
| 43 | schwannoma of jugular foramen | KG + DL |
| 44 | epiglottis neoplasm | KG + DL |
| 45 | benign neoplasm of floor of mouth | KG + DL |
| 46 | thyroglossal duct cyst | KG + DL |
| 47 | ductal or ductular proliferation | KG + DL |
| 48 | chondroid hamartoma | KG + DL |
| 49 | bronchial adenomas/carcinoids childhood | KG + DL |
| 50 | non-seminomatous lesion | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.